Prevalence and management of cancer-related anaemia, iron deficiency and the specific role of i.v. iron

The relationship between serum hepcidin levels and clinical outcomes in patients with chemotherapy-associated anemia treated in a controlled trial.

(2017) D. P. Steensma et al.   JOURNAL OF CLINICAL ONCOLOGY

Intravenous iron for the treatment of fatigue in nonanemic, premenopausal women with low serum ferritin concentration

(2011) P.-A. Krayenbuehl et al.   BLOOD

FERGIcor, a Randomized Controlled Trial on Ferric Carboxymaltose for Iron Deficiency Anemia in Inflammatory Bowel Disease

(2011) Rayko Evstatiev et al.   GASTROENTEROLOGY

Addition of iron to erythropoiesis-stimulating agents in cancer patients: a meta-analysis of randomized trials

(2011) Fausto Petrelli et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Reply to M. Aapro et al

(2011) David P. Steensma et al.   JOURNAL OF CLINICAL ONCOLOGY

Too-Low Iron Doses and Too Many Dropouts in Negative Iron Trial?

(2011) Matti Aapro et al.   JOURNAL OF CLINICAL ONCOLOGY

Do two intravenous iron sucrose preparations have the same efficacy?

(2011) J. Rottembourg et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Darbepoetin alfa 300 or 500 μg once every 3 weeks with or without intravenous Iron in patients with chemotherapy-induced anemia

(2010) Michael Auerbach et al.   AMERICAN JOURNAL OF HEMATOLOGY

American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer

(2010) J. D. Rizzo et al.   BLOOD

Blood transfusion reduction with intravenous iron in gynecologic cancer patients receiving chemotherapy

(2010) Penkae Dangsuwan et al.   GYNECOLOGIC ONCOLOGY

Phase III, Randomized Study of the Effects of Parenteral Iron, Oral Iron, or No Iron Supplementation on the Erythropoietic Response to Darbepoetin Alfa for Patients With Chemotherapy-Associated Anemia

(2010) David P. Steensma et al.   JOURNAL OF CLINICAL ONCOLOGY

The therapeutic equivalence of complex drugs

(2010) Huub Schellekens et al.   REGULATORY TOXICOLOGY AND PHARMACOLOGY

A new concept for the differential diagnosis and therapy of anaemia in cancer patients

(2010) H. Tilman Steinmetz et al.   SUPPORTIVE CARE IN CANCER

Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention

(2009) E. C. Vamvakas et al.   BLOOD

Role of iron in carcinogenesis: Cancer as a ferrotoxic disease

(2009) Shinya Toyokuni   CANCER SCIENCE

Treatment patterns and outcomes in the management of anaemia in cancer patients in Europe: Findings from the Anaemia Cancer Treatment (ACT) study

(2009) Heinz Ludwig et al.   EUROPEAN JOURNAL OF CANCER

Intensive Dose-Dense Compared With Conventionally Scheduled Preoperative Chemotherapy for High-Risk Primary Breast Cancer

(2009) Michael Untch et al.   JOURNAL OF CLINICAL ONCOLOGY

Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency

(2009) Stefan D. Anker et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Novel Intravenous Iron Formulation for Treatment of Anemia in Inflammatory Bowel Disease: The Ferric Carboxymaltose (FERINJECT®) Randomized Controlled Trial

(2008) Stefanie Kulnigg et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Iron metabolism in the anemia of chronic disease

(2008) Günter Weiss   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Efficacy of red blood cell transfusion in the critically ill: A systematic review of the literature*

(2008) Paul E. Marik et al.   CRITICAL CARE MEDICINE

The silent risks of blood transfusion

(2008) James Rawn   Current Opinion in Anesthesiology

Post-transcriptional Modulation of Iron Homeostasis during p53-dependent Growth Arrest

(2008) Fan Zhang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Randomized, Multicenter, Controlled Trial Comparing the Efficacy and Safety of Darbepoetin Alfa Administered Every 3 Weeks With or Without Intravenous Iron in Patients With Chemotherapy-Induced Anemia

(2008) Laurent Bastit et al.   JOURNAL OF CLINICAL ONCOLOGY

Randomized Trial of Intravenous Iron Supplementation in Patients With Chemotherapy-Related Anemia Without Iron Deficiency Treated With Darbepoetin Alfa

(2008) Paolo Pedrazzoli et al.   JOURNAL OF CLINICAL ONCOLOGY

Economic evaluation in Sweden of epoetin beta with intravenous iron supplementation in anaemic patients with lymphoproliferative malignancies not receiving chemotherapy

(2008) M. Hedenus et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Mechanisms of Myocyte Cytotoxicity Induced by the Multiple Receptor Tyrosine Kinase Inhibitor Sunitinib

(2008) B. B. Hasinoff et al.   MOLECULAR PHARMACOLOGY

September 2007 Update on EORTC Guidelines and Anemia Management with Erythropoiesis-Stimulating Agents

(2008) M. S. Aapro et al.   ONCOLOGIST